← FDA DRUG APPROVALS

FDA ANDA · ANDA071388

PROPRANOLOL HYDROCHLORIDE INTENSOL

Sponsor: ROXANE

APPLICATION
ANDA071388
TYPE
ANDA
ORIGINAL APPROVAL
1987-05-15
LATEST ACTION
2001-08-01
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

PROPRANOLOL HYDROCHLORIDE INTENSOLDiscontinued
PROPRANOLOL HYDROCHLORIDE 80MG/ML · CONCENTRATE · ORAL

Approval history

2001-08-01Labeling · Supplement 15AP
2001-02-20Manufacturing (CMC) · Supplement 14AP
2001-02-20Manufacturing (CMC) · Supplement 13AP
1996-08-28Manufacturing (CMC) · Supplement 10AP
1994-01-05Labeling · Supplement 9AP
1991-05-16Labeling · Supplement 8AP
1990-10-09Labeling · Supplement 7AP
1990-03-09Labeling · Supplement 6AP
1990-02-28Manufacturing (CMC) · Supplement 4AP
1990-01-16Labeling · Supplement 5AP
1988-12-21Manufacturing (CMC) · Supplement 2AP
1987-05-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →